Literature DB >> 19767045

Long-term follow-up of patients with incidentally discovered pancreatic cystic neoplasms evaluated by endoscopic ultrasound.

Nonthalee Pausawasdi1, David Heidt, Richard Kwon, Diane Simeone, James Scheiman.   

Abstract

BACKGROUND: The management of incidental pancreatic cysts is not well established because of lack of information on their natural history. International Consensus Guidelines advocate observation of asymptomatic patients with small lesions, despite limited data to support this approach.
METHODS: To characterize clinical outcomes in a cohort of asymptomatic patients with incidental pancreatic cysts who underwent endoscopic ultrasound (EUS) evaluation+/-fine needle aspiration (FNA).
RESULTS: Overall, 317 patients underwent EUS for evaluation of pancreatic cysts from 1995 to 2005. A total of 97/317 (31%) had asymptomatic, incidentally discovered pancreatic cysts; of 97 asymptomatic patients, 93 were contacted. Of these patients, 71/93 (76%) had lesions<3 cm and benign EUS features. All were followed without operative therapy. The mean follow-up was 44 months (range, 6-123). A total of 69/71 (97%) were alive and free of symptoms of pancreatic disease; 2 patients died of unrelated causes. Among these 71 patients with lesions<3 cm, FNA was performed in 33 patients and cytology was negative for malignant cells in all. Overall, 45/71 patients had either follow-up cross-sectional imaging or EUS. All of them had stable lesions. Surveillance studies were performed with a mean follow-up of 28 months (range, 4-120). The 22 patients with lesions >3 cm and/or concerning EUS features underwent resection. Pathologic analysis revealed that 2/22 patients had adenocarcinoma and that 60% had premalignant lesions.
CONCLUSION: Endoscopic ultrasound is helpful in evaluation of patients with small incidental pancreatic cystic lesions. Asymptomatic cysts with benign radiographic and/or endosonographic features may safely be followed clinically and with serial imaging. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767045     DOI: 10.1016/j.surg.2009.05.014

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

Review 1.  Natural History of Pancreatic Cysts.

Authors:  Alexander Larson; Richard S Kwon
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 2.  Pancreatic cystic lesions: when to watch, when to operate, and when to ignore.

Authors:  Brian G Turner; William R Brugge
Journal:  Curr Gastroenterol Rep       Date:  2010-04

3.  Natural history of asymptomatic pancreatic cystic neoplasms.

Authors:  Gareth Morris-Stiff; Gavin A Falk; Sricharan Chalikonda; R Matthew Walsh
Journal:  HPB (Oxford)       Date:  2012-07-23       Impact factor: 3.647

4.  Pancreatic cystic lesions: The value of contrast-enhanced endoscopic ultrasound to influence the clinical pathway.

Authors:  Michael Hocke; Xin-Wu Cui; Dirk Domagk; Andre Ignee; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2014-04       Impact factor: 5.628

5.  EUS Morphology Is Reliable in Selecting Patients with Mucinous Pancreatic Cyst(s) Most Likely to Benefit from Surgical Resection.

Authors:  Siddharth Javia; Satish Munigala; Sushovan Guha; Banke Agarwal
Journal:  Gastroenterol Res Pract       Date:  2017-09-07       Impact factor: 2.260

6.  Clinical outcomes of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions compared with the natural course: a propensity score matching analysis.

Authors:  Jin Ho Choi; Sang Hyub Lee; Young Hoon Choi; Jinwoo Kang; Woo Hyun Paik; Dong-Won Ahn; Ji Kon Ryu; Yong-Tae Kim
Journal:  Therap Adv Gastroenterol       Date:  2018-03-07       Impact factor: 4.409

7.  Long-term outcome of cystic lesions in the pancreas: a retrospective cohort study.

Authors:  Dong-Won Ahn; Sang Hyub Lee; Jaihwan Kim; Won Jae Yoon; Jin-Hyeok Hwang; Jin-Young Jang; Ji Kon Ryu; Yong-Tae Kim; Sun-Whe Kim; Yong Bum Yoon
Journal:  Gut Liver       Date:  2012-05-22       Impact factor: 4.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.